Skip to content
★ Sign in to follow
MT

Medlive Technology Co., Ltd. Stock: price and insider trades · Hong Kong

HK·Mcap HK$4.8BTechnology

No insider purchase over the last 90 days. The latest, by Tian Liping, was filed 01 Apr 2022.

Medlive Technology Co., Ltd.: what insiders have been doing

Medlive Technology Co., Ltd. is a Technology company. Its directors and officers file their transactions with HKEX. From 31 October 2025 to 31 October 2026, the disclosure feed for Medlive Technology Co., Ltd. logged 10 filings by 3 insiders.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

There has been no open-market purchase by an insider of Medlive Technology Co., Ltd. for at least a year. The median gap between a trade and its publication by HKEX is 5 days. This delay matters because a trade only becomes useful information once it is public.

With 10 filings in twelve months, the company is more active than the median of 4 filings across the 1,323 companies we follow on the same exchange. Over the whole record (from 2021), the tally stands at 3 purchases and 5 sales.

Other companies in the same sector with recent insider buying flagged by our signals: Basler Aktiengesellschaft and Lime Technologies AB (publ). Every figure here comes from the filings published by HKEX and describes the past, not future prices; it is not investment advice.

Insider Decl.
49
Thresholds
n/a
Buy Volume
€308,926
3 ops. · all time
Sell Volume
€2M
5 ops. · all time

Who traded when

BuySale
Tian Lijun3 sales

Since the insiders bought

  • Filed 01 Apr 2022 · 1682 days ago · €8,969
    +33.3%
    Entry HK$8.15 · Close at T+365 HK$10.86

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 4,587 of 26,897 companies
68.9
score / 100
Value
56
Quality
82
FCF yld2.5%
Earn yld6.9%
EV/EBITDA12.7x
ROE7.3%
Gross mgn60%
Net mgn52%
Debt/EBITDA0.0x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

HK$6.52
Analyst consensus
5 analysts
1.00/5
HK$9.04Target HK$10.49(+61%)HK$11.59
Income statement
RevenueHK$642.2M
Gross profitHK$385.4M60% margin
EBITDAHK$381.9M59% margin
Net incomeHK$334.3M52.8% margin
Valuation
PER (trailing)12.5x
PER (forward)12.1x
P/Book0.9x
Beta0.52
Balance sheet & cash
Market capHK$4.8B
Total debtHK$10.1M
Free Cash FlowHK$121.7M
Debt / Equity0%
Profitability & ownership
ROE7.3%
ROA2.3%
% insiders74.2%
% institutions17.3%
Last declaration on 9 April 2026
Declarations49 total
  • ●
    DirectorExecutives
    0HKEX
    137,500 sharesShareXHKGHKEX:DA20260409E00097
  • ●
    DirectorExecutives
    0HKEX
    137,500 sharesShareXHKGHKEX:DA20260409E00095
  • ●
    DirectorExecutives
    0HKEX
    700,000 sharesShareXHKGHKEX:DA20260409E00111
  • ●
    DirectorExecutives
    0HKEX
    300,000 sharesShareXHKGHKEX:DA20260305E00014
  • ●
    DirectorExecutives
    0HKEX
    200,000 sharesShareXHKGHKEX:DA20260227E00022
  • ●
    DirectorExecutives
    0HKEX
    500,000 sharesShareXHKGHKEX:DA20260106E00146
  • ●
    DirectorExecutives
    0HKEX
    200,000 sharesShareXHKGHKEX:DA20260106E00142
  • ●
    DirectorExecutives
    0HKEX
    300,000 sharesShareXHKGHKEX:DA20251212E00140
  • ●
    DirectorExecutives
    0HKEX
    500,000 sharesShareXHKGHKEX:DA20251212E00126
  • ●
    DirectorExecutives
    0HKEX
    300,000 sharesShareXHKGHKEX:DA20251212E00134
  • ●
    DirectorExecutives
    0HKEX
    534,500 sharesShareXHKGHKEX:DA20251016E00027
  • ▼
    DirectorExecutives
    4M HKD13HKEX
    240,000 shares@ HK$15.02521.9% of flowShareXHKGHKEX:DA20250718E00407
  • ▼
    DirectorExecutives
    3M HKD13HKEX
    211,000 shares@ HK$15.084219.3% of flowShareXHKGHKEX:DA20250718E00337
  • ▼
    DirectorExecutives
    7M HKD15HKEX
    449,000 shares@ HK$14.876440.4% of flowShareXHKGHKEX:DA20250718E00299
  • ●
    DirectorExecutives
    0HKEX
    237,500 sharesShareXHKGHKEX:DA20240729E00011
  • ●
    DirectorExecutives
    0HKEX
    834,500 sharesShareXHKGHKEX:DA20240729E00007
  • ●
    DirectorExecutives
    0HKEX
    237,500 sharesShareXHKGHKEX:DA20240729E00009
  • ●
    DirectorExecutives
    0HKEX
    200,000 sharesShareXHKGHKEX:DA20240726E00027
  • ●
    DirectorExecutives
    0HKEX
    500,000 sharesShareXHKGHKEX:DA20240726E00023
  • ●
    DirectorExecutives
    0HKEX
    200,000 sharesShareXHKGHKEX:DA20240723E00073
  • ●
    DirectorExecutives
    0HKEX
    1,200,000 sharesShareXHKGHKEX:DA20240723E00065
  • ●
    DirectorExecutives
    0HKEX
    400,000 sharesShareXHKGHKEX:DA20240723E00068
  • ●
    DirectorExecutives
    0HKEX
    637,500 sharesShareXHKGHKEX:DA20230724E00007
  • ●
    DirectorExecutives
    0HKEX
    637,500 sharesShareXHKGHKEX:DA20230721E00048
  • ●
    DirectorExecutives
    0HKEX
    2,534,500 sharesShareXHKGHKEX:DA20230721E00045

25 of 49 declarations

About Medlive Technology Co., Ltd.

Medlive Technology Co., Ltd. is a company focused on developing technological solutions for the healthcare sector. It is listed on the Hong Kong Stock Exchange.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations